| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
3
3
4
5
1
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
E-
(Sell)
|
#57 in Intermediate-Term Bond
U.S. News evaluated 320 Intermediate-Term Bond Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.
Performance
The fund has returned 14.66 percent over the past year, 6.97 percent over the past three years, 7.17 percent over the past five years, and 5.29 percent over the past decade.
| Trailing Returns | Updated 04.30.2013 |
|---|---|
| Year to date | 5.1% |
| 1 Year | 14.7% |
| 3 Years (Annualized) | 7.0% |
| 5 Years (Annualized) | 7.2% |
| 10 Years (Annualized) | 5.3% |
Summary
The investment seeks total return in excess of that of its benchmark, the Barclays U.S. Government Index. The fund is not pursuing an active investment program and is gradually liquidating its portfolio. It principally holds shares of Short-Duration Collateral fund. The fund has also invested in and may continue to hold U.S. bonds. It normally invests directly and indirectly at least 80% of its assets in bonds tied economically to the U.S. The fund is non-diversified.
Fees
Fees are Average compared to funds in the same category.
GMO Domestic Bond Fund has an expense ratio of 0.21 percent.
Risk
Risk is Above Average compared to funds in the same category according to Morningstar.
